In further support of this crosstalk, U373 glioma cells demonstrated robust Src activation upon treatment with exogenous Hsp90 protein, the specificity of which was confirmed by abrogation by NPGA (Figure 3B). The gene discussed is HSP90AA1; the disease is central nervous system cancer.